Researchers discovered a neural activity pattern that can accurately predict and monitor the clinical status of OCD patients undergoing deep brain stimulation (DBS). The study highlights how this biomarker can guide DBS therapy, improving treatment outcomes for those with severe, treatment-resistant OCD.